[ABCL] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
04-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -38.39%
YoY- -78.63%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 6,507 6,599 101,383 5,508 9,362 3,451 13.50%
PBT -62,632 -39,276 46,587 -24,972 -2,693 36 -
Tax -11,525 -10,666 19,963 -3,592 0 0 -
NP -51,107 -28,610 26,624 -21,380 -2,693 36 -
Tax Rate - - -42.85% - - 0.00% -
Total Cost 57,614 35,209 74,759 26,888 12,055 3,415 75.85%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin -785.42 -433.55 26.26 -388.16 -28.77 1.04 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.17 -0.10 0.08 -0.08 -0.01 0.00 -
EPS Diluted -0.17 -0.10 0.08 -0.08 -0.01 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.